NICE Single Technology Appraisal: Cabazitaxel for treating hormone relapsed metastatic prostate cancer after a docetaxel-containing regimen (review of TA255) [ID889]

M. Satish Kumar, Benjamin Kearns*, Abdullah Pandor, Matt Stevenson, Jean Hamilton, Duncan Chambers, Mark Clowes, John Graham

*Corresponding author for this work

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Number of pages573
Publication statusPublished - Apr 2016

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this